UNASSIGNED: Here, we present a patient with PD. We investigated whether an accelerate form of high-frequency (HF) rTMS on the contralateral side to the patient\'s main difficulties is clinically effective in treating health-related quality of life (QoL) symptomatology and depressive symptoms in PD as well as the long-term effects of rTMS in PD during the maintenance phase.
UNASSIGNED: Results showed that HF-rTMS administered over the right primary motor cortex (M1) is a safe and well-tolerated treatment that improved the patient\'s health related QoL and depressive symptoms. These positive effects lasted at least five months post treatment.
UNASSIGNED: Therefore, HF-rTMS over the right M1 can be a possible treatment option for patients with PD, although further investigations are necessary to validate the findings of the present case report.
未经评估:这里,我们介绍了一名PD患者。我们调查了在患者主要困难的对侧加速形式的高频(HF)rTMS是否在临床上有效治疗与健康相关的生活质量(QoL)症状和抑郁症状,以及在维持阶段rTMS在PD中的长期影响。
UNASSIGNED:结果显示,在右初级运动皮质(M1)上给予HF-rTMS是一种安全且耐受性良好的治疗方法,可改善患者的健康相关QoL和抑郁症状。这些积极作用在治疗后持续至少5个月。
UNASSIGNED:因此,HF-rTMS超过右侧M1可能是PD患者的可能治疗选择,尽管需要进一步调查以验证本病例报告的发现。